α-Synuclein mutations cluster around a putative protein loop

Neuroscience Letters

Volumn 546, Issue , 2013, Pages 67-70

  Kara, Eleanna ^a   Lewis, Patrick A ^a,b   Ling, Helen ^a   Proukakis, Christos ^c   Houlden, Henry ^a   Hardy, John ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF READING   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Synuclein; Genetics; Parkinson's disease; SNCA

Indexed keywords

ALPHA SYNUCLEIN; AMINO ACID; TETRAMER;

AMINO ACID SUBSTITUTION; ARTICLE; GENE CLUSTER; GENE LOCATION; PATHOGENESIS; POINT MUTATION; PRIORITY JOURNAL; PROTEIN QUATERNARY STRUCTURE;

ALPHA-SYNUCLEIN; AMINO ACID SEQUENCE; HUMANS; MOLECULAR SEQUENCE DATA; MULTIGENE FAMILY; POINT MUTATION; PROTEIN CONFORMATION;

EID: 84878910950     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.04.058     Document Type: Article

References (43)

1. Appel-Cresswell S., Vilarino-Guell C., Encarnacion M., Sherman H., Yu I., Shah B., Weir D., Thompson C., Szu-Tu C., Trinh J., Aasly J.O., Rajput A., Rajput A.H., Jon Stoessl A., Farrer M.J. Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease. Mov. Disord. 2013, 10.1002/mds.25421.
2. Bartels T., Choi J.G., Selkoe D.J. alpha-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Nature 2011, 477:107-110.
3. Binolfi A., Lamberto G.R., Duran R., Quintanar L., Bertoncini C.W., Souza J.M., Cervenansky C., Zweckstetter M., Griesinger C., Fernandez C.O. Site-specific interactions of Cu(II) with alpha and beta-synuclein: bridging the molecular gap between metal binding and aggregation. J. Am. Chem. Soc. 2008, 130:11801-11812.
4. Binolfi A., Theillet F.X., Selenko P. Bacterial in-cell NMR of human alpha-synuclein: a disordered monomer by nature?. Biochem. Soc. Trans. 2012, 40:950-954.
5. Braak H., Del Tredici K., Rub U., de Vos R.A., Jansen Steur E.N., Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 2003, 24:197-211.
6. Chartier-Harlin M.C., Kachergus J., Roumier C., Mouroux V., Douay X., Lincoln S., Levecque C., Larvor L., Andrieux J., Hulihan M., Waucquier N., Defebvre L., Amouyel P., Farrer M., Destee A. Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet 2004, 364:1167-1169.
7. Cremades N., Cohen S.I., Deas E., Abramov A.Y., Chen A.Y., Orte A., Sandal M., Clarke R.W., Dunne P., Aprile F.A., Bertoncini C.W., Wood N.W., Knowles T.P., Dobson C.M., Klenerman D. Direct observation of the interconversion of normal and toxic forms of alpha-synuclein. Cell 2012, 149:1048-1059.
8. Croke R.L., Patil S.M., Quevreaux J., Kendall D.A., Alexandrescu A.T. NMR determination of pKa values in alpha-synuclein. Protein Sci. 2011, 20:256-269.
9. Cuervo A.M., Stefanis L., Fredenburg R., Lansbury P.T., Sulzer D. Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science 2004, 305:1292-1295.
10. Davidson W.S., Jonas A., Clayton D.F., George J.M. Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes. J. Biol. Chem. 1998, 273:9443-9449.
11. Davies P., McHugh P.C., Hammond V.J., Marken F., Brown D.R. Contribution of individual histidines to prion protein copper binding. Biochemistry 2011, 50:10781-10791.
12. Davies P., Wang X., Sarell C.J., Drewett A., Marken F., Viles J.H., Brown D.R. The synucleins are a family of redox-active copper binding proteins. Biochemistry 2011, 50:37-47.
13. Dettmer U., Newman A.J., Luth E.S., Bartels T., Selkoe D. In vivo crosslinking reveals principally oligomeric forms of alpha-synuclein and beta-synuclein in neurons and non-neural cells. J. Biol. Chem. 2013, 288(9):6371-6385.
14. Devine M.J., Ryten M., Vodicka P., Thomson A.J., Burdon T., Houlden H., Cavaleri F., Nagano M., Drummond N.J., Taanman J.W., Schapira A.H., Gwinn K., Hardy J., Lewis P.A., Kunath T. Parkinson's disease induced pluripotent stem cells with triplication of the alpha-synuclein locus. Nat. Commun. 2011, 2:440.
15. Dudzik C.G., Walter E.D., Abrams B.S., Jurica M.S., Millhauser G.L. Coordination of copper to the membrane-bound form of alpha-synuclein. Biochemistry 2013, 52:53-60.
16. Dudzik C.G., Walter E.D., Millhauser G.L. Coordination features and affinity of the Cu(2)+ site in the alpha-synuclein protein of Parkinson's disease. Biochemistry 2011, 50:1771-1777.
17. Fauvet B., Mbefo M.K., Fares M.B., Desobry C., Michael S., Ardah M.T., Tsika E., Coune P., Prudent M., Lion N., Eliezer D., Moore D.J., Schneider B., Aebischer P., El-Agnaf O.M., Masliah E., Lashuel H.A. alpha-Synuclein in central nervous system and from erythrocytes, mammalian cells, and Escherichia coli exists predominantly as disordered monomer. J. Biol. Chem. 2012, 287:15345-15364.
18. Fredenburg R.A., Rospigliosi C., Meray R.K., Kessler J.C., Lashuel H.A., Eliezer D., Lansbury P.T. The impact of the E46 K mutation on the properties of alpha-synuclein in its monomeric and oligomeric states. Biochemistry 2007, 46:7107-7118.
19. Fuchs J., Nilsson C., Kachergus J., Munz M., Larsson E.M., Schule B., Langston J.W., Middleton F.A., Ross O.A., Hulihan M., Gasser T., Farrer M.J. Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication. Neurology 2007, 68:916-922.
20. Gasser T., Hardy J., Mizuno Y. Milestones in PD genetics. Mov. Disord. 2011, 26:1042-1048.
21. Gurry T., Ullman O., Fisher C.K., Perovic I., Pochapsky T., Stultz C.M. The dynamic structure of alpha-synuclein multimers. J. Am. Chem. Soc. 2013, 135:3865-3872.
22. Gwinn K., Devine M.J., Jin L.W., Johnson J., Bird T., Muenter M., Waters C., Adler C.H., Caselli R., Houlden H., Lopez G., Singleton A., Hardy J. Clinical features, with video documentation, of the original familial Lewy body Parkinsonism caused by alpha-synuclein triplication (Iowa kindred). Mov. Disord. 2011, 26:2134-2136.
23. Hardy J. Expression of normal sequence pathogenic proteins for neurodegenerative disease contributes to disease risk: 'permissive templating' as a general mechanism underlying neurodegeneration. Biochem. Soc. Trans. 2005, 33:578-581.
24. Hardy J. Framing beta-amyloid. Nat. Genet. 1992, 1:233-234.
25. Hardy J., Crook R. Presenilin mutations line up along transmembrane alpha-helices. Neurosci. Lett. 2001, 306:203-205.
26. Hardy J., Revesz T. The spread of neurodegenerative disease. N. Engl. J. Med. 2012, 366:2126-2128.
27. Kiely A.P., Asi Y.T., Kara E., Limousin P., Ling H., Lewis P., Proukakis C., Quinn N., Lees A.J., Hardy J., Revesz T., Houlden H., Holton J.L. alpha-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson's disease and multiple system atrophy?. Acta Neuropathol. 2013, 125(5):753-769.
28. Kordower J.H., Chu Y., Hauser R.A., Freeman T.B., Olanow C.W. Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nat. Med. 2008, 14:504-506.
29. Kruger R., Kuhn W., Muller T., Woitalla D., Graeber M., Kosel S., Przuntek H., Epplen J.T., Schols L., Riess O. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat. Genet. 1998, 18:106-108.
30. Lesage S., Anheim M., Letournel F., Bousset L., Honore A., Rozas N., Pieri L., Madiona K., Durr A., Melki R., Verny C., Brice A. G51D alpha-synuclein mutation causes a novel Parkinsonian-pyramidal syndrome. Ann. Neurol. 2013, 10.1002/ana.23894.
31. Li J.Y., Englund E., Holton J.L., Soulet D., Hagell P., Lees A.J., Lashley T., Quinn N.P., Rehncrona S., Bjorklund A., Widner H., Revesz T., Lindvall O., Brundin P. Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat. Med. 2008, 14:501-503.
32. Mazzulli J.R., Xu Y.H., Sun Y., Knight A.L., McLean P.J., Caldwell G.A., Sidransky E., Grabowski G.A., Krainc D. Gaucher disease glucocerebrosidase and alpha-synuclein form a bidirectional pathogenic loop in synucleinopathies. Cell 2011, 146:37-52.
33. Mizutani T., Inose T., Nakajima S., Kakimi S., Uchigata M., Ikeda K., Gambetti P., Takasu T. Familial Parkinsonism and dementia with ballooned neurons, argyrophilic neuronal inclusions, atypical neurofibrillary tangles, tau-negative astrocytic fibrillary tangles, and Lewy bodies. Acta Neuropathol. 1998, 95:15-27.
34. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W.G., Lazzarini A.M., Duvoisin R.C., Di Iorio G., Golbe L.I., Nussbaum R.L. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997, 276:2045-2047.
35. Proukakis C., Dudzik C.G., Brier T., Mackay D.S., Cooper J.M., Millhauser G.L., Houlden H., Schapira A.H. A novel alpha-synuclein missense mutation in Parkinson disease. Neurology 2013, 80(11):1062-1064.
36. Rubinsztein D.C., DiFiglia M., Heintz N., Nixon R.A., Qin Z.H., Ravikumar B., Stefanis L., Tolkovsky A. Autophagy and its possible roles in nervous system diseases, damage and repair. Autophagy 2005, 1:11-22.
37. Singleton A.B., Farrer M., Johnson J., Singleton A., Hague S., Kachergus J., Hulihan M., Peuralinna T., Dutra A., Nussbaum R., Lincoln S., Crawley A., Hanson M., Maraganore D., Adler C., Cookson M.R., Muenter M., Baptista M., Miller D., Blancato J., Hardy J., Gwinn-Hardy K. alpha-Synuclein locus triplication causes Parkinson's disease. Science 2003, 302:841.
38. Trexler A.J., Rhoades E. N-terminal acetylation is critical for forming alpha-helical oligomer of alpha-synuclein. Protein Sci. 2012, 21:601-605.
39. Ulmer T.S., Bax A., Cole N.B., Nussbaum R.L. Structure and dynamics of micelle-bound human alpha-synuclein. J. Biol. Chem. 2005, 280:9595-9603. 10.2210/pdb1xq8/pdb.
40. Valiente-Gabioud A.A., Torres-Monserrat V., Molina-Rubino L., Binolfi A., Griesinger C., Fernandez C.O. Structural basis behind the interaction of Zn(2)(+) with the protein alpha-synuclein and the Abeta peptide: a comparative analysis. J. Inorg. Biochem. 2012, 117:334-341.
41. Wang W., Perovic I., Chittuluru J., Kaganovich A., Nguyen L.T., Liao J., Auclair J.R., Johnson D., Landeru A., Simorellis A.K., Ju S., Cookson M.R., Asturias F.J., Agar J.N., Webb B.N., Kang C., Ringe D., Petsko G.A., Pochapsky T.C., Hoang Q.Q. A soluble alpha-synuclein construct forms a dynamic tetramer. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:17797-17802.
42. Xilouri M., Vogiatzi T., Vekrellis K., Park D., Stefanis L. Abberant alpha-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy. PLoS ONE 2009, 4:e5515.
43. Zarranz J.J., Alegre J., Gomez-Esteban J.C., Lezcano E., Ros R., Ampuero I., Vidal L., Hoenicka J., Rodriguez O., Atares B., Llorens V., Gomez Tortosa E., del Ser T., Munoz D.G., de Yebenes J.G. The new mutation, E46 K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann. Neurol. 2004, 55:164-173.